Odyssey Therapeutics ODTX
NASDAQ ODTX
$19.36 +0.22 (+1.15%)
At close: Nov 16, 2026 · 4:00 PM EST

Odyssey Therapeutics (ODTX) Enterprise Value (2026)

Updated

Odyssey Therapeutics' Enterprise Value was $739.24 million in Q3 2026, up 188.9% from the prior quarter.

Analysis

Odyssey Therapeutics (ODTX) Enterprise Value (2026) Analysis & Trends

On a trailing twelve-month basis, Odyssey Therapeutics' Enterprise Value was $71.56 million through Sep 30, 2026.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Odyssey Therapeutics 929.15 Mn -64.53 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 739.24 Mn
Jun 30, 2026 255.91 Mn
API Access

Odyssey Therapeutics Enterprise Value API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=enterprise-value&ticker=ODTX&period=max&api_key=YOUR_API_KEY